Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis
Keywords:itch, pruritus, prurigo nodularis, PN, atopic dermatitis, AD, sleep
Abstract is missing (Short communication)
Silverberg JI, Kantor RW, Dalal P, Hickey C, Shaunfield S, Kaiser K, et al. A comprehensive conceptual model of the experience of chronic itch in adults. Am J Clin Dermatol 2018; 19: 759-769.
Steinke S, Zeidler C, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol 2018; 79: 457-463.
Lavery MJ, Stull C, Nattkemper LA, Sanders KM, Lee H, Sahu S, et al. Nocturnal pruritus: prevalence, characteristics, and impact on ItchyQoL in a chronic itch population. Acta Derm Venereol 2017; 97: 513-515.
Todberg T, Zachariae C, Skov L. Treatment and burden of disease in a cohort of patients with prurigo nodularis: a survey-based study. Acta Derm Venereol 2020; 100: adv00119.
Konda D, Chandrashekar L, Rajappa M. Kattimani S, Thappa DM, Ananthanarayanan PH. Serotonin and interleukin-6: association with pruritus severity, sleep quality and depression severity in prurigo nodularis. Asian J Psychiatr 2015; 17: 24-28.
Spring P, Gschwind I, Gilliet M. Prurigo nodularis: retrospective study of 13 cases managed with methotrexate. Clin Exp Dermatol 2014; 39: 468-473.
Sharma AD. Oral ketotifen and topical antibiotic therapy in the management of pruritus in prurigo nodularis: a randomized, controlled, single-blind, parallel study. Indian J Dermatol 2013; 58: 355-359.
Oh CC, Li H, Lee W, Tey HL. Biopsychosocial factors associated with prurigo nodularis in endogenous eczema. Indian J Dermatol 2015; 60: 525.
Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009; 160: 642-644.
Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol 2008; 59: 234-244.
Gwillim EC, Janmohamed SR, Yousaf M, Patel KR, Silverberg JI. The impact of prurigo nodularis on sleep disturbance and related impact: a systematic review. J Eur Acad Dermatol Venereol 2020; 34: e815-e817.
Pereira MP, Hoffmann V, Weisshaar E, Wallengren J, Halvorsen JA, Garcovich S, et al. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. J Eur Acad Dermatol Venereol 2020; 34: 2373-2383.
Ferrucci S, Tavecchio S, Berti E, Angileri L. Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy. J Dermatolog Treat 2019 Sep 2 [Epub ahead of print].
Chiricozzi A, Maurelli M, Gori N, Argenziano G, De Simone C, Calabrese G, et al. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo. J Am Acad Dermatol 2020; 83: 39-45.
Ständer S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med 2020; 382: 706-716.
How to Cite
Copyright (c) 2021 Eran C. Gwillim, Leigh A. Nattkemper, Gil Yosipovitch
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.